Propanc Biopharma (PPCB) Cash from Financing Activities (2011 - 2025)
Propanc Biopharma (PPCB) recorded Cash from Financing Activities of $6.46 million in FY2026 (year ended Jun 30, 2026), compared with $490,756 in FY2025.
Powered by 
Analysis
Propanc Biopharma (PPCB) Cash from Financing Activities (2011 - 2025) Analysis & Trends
Starting with FY2011, Propanc Biopharma's Cash from Financing Activities history includes 16 fiscal years.
- Annual Cash from Financing Activities has a five-year compound annual growth rate of 43.6% (FY2021 to FY2026).
- The FY2026 figure is the highest annual Cash from Financing Activities in data going back to FY2011.
- Per Business Quant data, PPCB's Cash from Financing Activities was $490,756 in FY2025 (-47.9%), $941,894 in FY2024 (-15.4%), $1.11 million in FY2023 (-25.3%) and $1.49 million in FY2022 (+40.9%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | -8.78 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | -5.05 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 1.76 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | -2.02 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | -47.00 Mn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | -1.48 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 2.34 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | -3.66 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | -426.70 Mn |
| 10 | Propanc Biopharma | 550,617.42 | 550,617.42 | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 965,099.00 |
| Sep 30, 2025 | 2.53 Mn |
| Jun 30, 2025 | 7,756.00 |
| Mar 31, 2025 | 212,485.00 |
| Dec 31, 2024 | 54,816.00 |
| Sep 30, 2024 | 215,699.00 |
| Jun 30, 2024 | 250,974.00 |
| Mar 31, 2024 | 66,644.00 |
| Dec 31, 2023 | 273,929.00 |
| Sep 30, 2023 | 350,347.00 |
| Jun 30, 2023 | 100,000.00 |
| Mar 31, 2023 | 269,500.00 |
| Dec 31, 2022 | 250,000.00 |
| Sep 30, 2022 | 494,219.00 |
| Jun 30, 2022 | 374,286.00 |
| Mar 31, 2022 | 327,000.00 |
| Dec 31, 2021 | 354,500.00 |
| Sep 30, 2021 | 435,000.00 |
| Jun 30, 2021 | 250,000.00 |
| Mar 31, 2021 | 450,000.00 |
API Access
Propanc Biopharma Cash from Financing Activities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-from-financing-activities&ticker=PPCB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-from-financing-activities", "ticker": "PPCB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-from-financing-activities&ticker=PPCB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();